Levy Raphi 4

What Happened

• Raphi Levy, Chief Financial Officer of Alpha Tau Medical (DRTS), reported sales totaling 17,500 shares on 2026-06-23. The filing shows two dispositions: 15,000 shares at $9.47 each ($142,050) and 2,500 shares at $10.00 each ($25,001), for aggregate proceeds of approximately $167,051. These were sales (Form 4 code "S"), not purchases.

Key Details

• Transaction dates and prices: 2026-06-23 — 15,000 shares @ $9.47 and 2,500 shares @ $10.00.
• Total shares sold: 17,500; total proceeds ≈ $167,051.
• Shares owned after transaction: Not provided in the excerpt supplied.
• Footnotes/plan: The provided filing excerpt does not indicate a 10b5-1 trading plan, tax withholding sale, or other special footnotes.
• Timeliness: Report filed 2026-06-25 for a 2026-06-23 transaction — filing appears timely (within standard reporting window).

Context

• These are sales, which are commonly routine (e.g., diversification or liquidity) and do not by themselves indicate company outlook; purchases are generally more informative about insider sentiment.
• Transaction code S = sale; no derivative exercises or awards were reported in this filing.